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A report on the 62nd Annual Meeting for the Society for
Developmental Biology (SDB), Boston, USA, 30 July to
3 August 2003.
Developmental biologists from around the world converged
on Boston for the SDB annual meeting to discuss topics that
ranged from embryonic development in invertebrates to
mammalian stem cells. Genomic approaches are driving
many new discoveries in developmental biology, as was
reflected in several plenary-session talks and a special work-
shop that featured genomic and proteomic applications. A
few of the highlights are described here.
Fast forward with reverse genetics 
The first few cell divisions in an organism’s life are a
complex affair. Mutational approaches in the embryo of
Caenorhabditis elegans have identified genes involved in
asymmetric cell division, coordinated centrosome move-
ments and proper segregation of chromosomes. Many - in
fact most - of the genes required for normal early embryonic
development are only now being identified, however, thanks
to high-throughput RNA interference (RNAi) screening.
Fabio Piano (New York University, USA) described how
large-scale functional genomics has been merged with
careful developmental analysis of the events of early
C. elegans embryogenesis. Piano, in parallel with other
groups such as those of Julie Ahringer (The Wellcome
Trust/Cancer Research UK Institute, Cambridge, UK) and
Tony Hyman (Max Planck Institute for Molecular Cell
Biology and Genetics, Dresden, Germany), has been using
RNAi combined with high-resolution embryo imaging to
investigate the functions of predicted C. elegans genes.
Piano presented an evaluation of his own and the other
groups’ datasets, comparing them by the RNAi delivery tech-
nique used: soaking worms in double-stranded RNA
(dsRNA), feeding them bacteria expressing dsRNA, or
injecting dsRNA directly. Each group scored embryos for a
standard set of phenotypes. Although there was significant
overlap in the genes identified, Piano found that a large pro-
portion of genes identified by each screen were not found by
the others, indicating that multiple iterations of RNAi
screening will be necessary to approach truly comprehensive
coverage of the genome. 
Piano also described a novel method his group is using to
organize the large amounts of data produced from the RNAi
screens. Genes are clustered on the basis of a standardized
vocabulary that describes the phenotypes observed from the
screen; this reveals functionally related genes solely on the
basis of the constellation of phenotypes they affect. For
example, Piano and colleagues identified genes involved in
DNA replication and repair that are associated with ‘exag-
gerated asynchrony’ of the early cell divisions that produce
the four-cell embryo. This ‘pheno-clustering’ approach
promises to be of great utility for interpreting data from the
increasing number of RNAi screens being carried out in
C. elegans and other model systems.
RNAi is also a screening tool of choice in Drosophila. Amy
Kiger (Harvard Medical School, Boston, USA) presented her
RNAi loss-of-function screen in Drosophila cells, in which
double-stranded RNA transcribed in vitro is used directly in
cultured S2 embryonic cells. Kiger has screened approxi-
mately 91% of the predicted genes in the Drosophila genome
for their effects on cytoskeletal components that influence
cell morphology and cell size, digitally recording the effects
of each RNAi soaking treatment after fixing and staining the
cells to visualize actin, tubulin and DNA. Kiger has detected
RNAi phenotypes for over 400 genes in her screen. Some of
these genes, such as cdc42, have alleles already known to
cause cell-morphology defects in animals, but the majority
(81%) of the genes she has found have not previously been
studied in Drosophila. Craig Hunter’s group (Harvard University, Cambridge, USA)
is investigating the mechanisms that produce systemic
spread of RNAi throughout the organism. Through a cleverly
designed screen, they have identified two transmembrane
proteins that are needed for dsRNA to get into and out of
cells. Hunter’s group has tested the function of one of these
C. elegans proteins, SID-1, in Drosophila cell culture, and
he described how the efficiency of RNAi in Drosophila cells
can be increased by several thousand-fold by supplying
SID-1 expressed from a transgene; SID-1 appears to be
required for cells to take up dsRNA efficiently. In contrast to
C. elegans, systemic RNAi does not occur naturally in
Drosophila, but if this method of expressing C. elegans
SID-1 works in whole flies, it could prove a powerful addition
to the fly-researcher’s toolbox.
Another version of RNA-based silencing was the focus of a
talk by Bonnie Bartel (Rice University, Houston, USA). Her
group has cloned a number of potential microRNAs
(miRNAs) from a pool of small endogenous RNAs in Ara-
bidopsis by searching for sequences similar to those of
known miRNAs that form the characteristic hairpin precur-
sors processed by the enzyme Dicer. Using data mining of
the sequenced Arabidopsis genome, Bartel’s group has made
predictions about the regulatory targets of miRNAs and their
mechanism of action in development. For example, on the
basis of perfect sequence complementarity, a single miRNA,
miR171, is expected to regulate three genes that code for
Scarecrow-like transcription factors. In a comparison of the
Arabidopsis and rice genomic sequences, Bartel’s group has
also found that half of these miRNAs, as well as a number of
the potential target sites, are absolutely conserved. Although
Bartel did not present direct evidence for the function of
these novel miRNAs during development, she mentioned
previous work by Steven Jacobsen and colleagues (Univer-
sity of California, Los Angeles, USA), who have shown that
disrupting the machinery used to process miRNAs does lead
to developmental defects in Arabidopsis, such as cell prolif-
eration in floral meristems. Determination of the specific
developmental function of each of the predicted miRNAs is
eagerly anticipated.
Morpholino oligonucleotides are another example of func-
tional interference-based technology that takes advantage of
the newly sequenced genomes. The classic use of morpholi-
nos has been a reverse-genetic approach - to block translation
of previously identified genes to monitor their role in devel-
opment. Steve Ekker (University of Minnesota, Minneapolis,
USA) presented a strategy in which morpholinos are used to
screen for developmental regulatory genes in zebrafish. Mor-
pholinos against zebrafish expressed sequence tags (ESTs)
for secreted proteins with high similarity to mouse, Fugu
and human ESTs were tested for their ability to induce
developmental phenotypes. This strategy has identified new
functions in vivo for both known and unknown genes. For
example, Ekker described zebrafish ‘morphants’ in which the
transmembrane heparan-sulfate proteoglycan Syndecan 2
has been targeted with a morpholino. These morphants have
defects in angiogenic sprouting of blood vessels that can be
rescued by expression of human Syndecan. Ekker described
how a consortium of labs is taking advantage of the screen.
For instance, Steve Farber (Thomas Jefferson University,
Philadelphia, USA) is testing for genes involved in lipid
metabolism, while Matthias Hammerschmidt’s lab (Max
Planck Institute for Immunobiology, Freiburg, Germany) is
focusing on embryo morphology. 
Proteomics in living cells
Developmental biologists like to see exactly where their
favorite proteins are, but visualizing the location of each
protein under study can require careful optimization of anti-
bodies or green fluorescent protein (GFP)-tagged trans-
genes. Antibodies can only give limited information,
however, as staining patterns in fixed tissue cannot reflect
the dynamics of protein localization, and often, because of
fixation artifacts, subcellular antibody staining patterns may
not reflect the localization of the protein in vivo. For organ-
isms without efficient homologous recombination (such as
Drosophila, C. elegans and zebrafish), GFP tags cannot be
specifically incorporated into the genome and GFP tagging
has relied on transgenic approaches that can result in over-
expression of a protein and can thus yield potentially unreli-
able results. 
Ideally, one would like to do what has been done in yeast -
tag each gene in situ with a GFP sequence and then visualize
the protein as it is expressed from the gene’s natural position
in the genome. For a large proportion of the proteins in the
Drosophila genome, Lynn Cooley (Yale University, New
Haven, USA) may have found a way to do just this. She
described how, in collaboration with Bill Chia (King’s
College, London, UK) and Allan Spradling (Carnegie Institu-
tion of Washington, Baltimore, USA), her group is using the
well-established P-element system to mobilize a transpos-
able element that contains a GFP open reading frame
flanked by splice-acceptor and splice-donor sequences.
Upon mobilization, this P element jumps semi-randomly
throughout the genome, and when it lands in an intron
(more than 75% of Drosophila genes have at least one
intron) it has a one in six chance of making an in-frame
fusion protein (one in three for being in the right frame and
one in two for being in the right orientation). Because
landing in an intron is rare enough in itself for a P element,
correctly oriented intronic insertions only happen about
once in 2,000 jumps. Thus, millions of embryos must be
screened to get a reasonable proportion of the proteome rep-
resented. Cooley’s solution is to assay 20 embryos per
second for GFP fluorescence in a high-speed fluorescence-
activated live-animal sorter. Cooley’s group has already
screened several million embryos this way, and has isolated
more than 1,000 GFP-fusion insertions. They are following
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to cytoskeletal components of the Drosophila ovary, and
several other groups have begun to screen the fly strains for
protein localization patterns in other tissues. Cooley pre-
sented videos of the actin cytoskeleton that reveal dynamics
and structure that had previously been undocumented using
traditional fixation and antibody approaches. 
Notably, most of the insertions do not affect normal protein
function:  several essential genes have been successfully
trapped and made homozygous. This strategy promises to
yield a valuable reagent for a large proportion of the more
than 14,000 protein-coding genes in the Drosophila genome,
and could potentially revolutionize cell biological studies of
Drosophila development. Will zebrafish be next for this
transposon-based approach?
Profiling embryonic stem cells 
A great deal of research is currently directed to deciphering
the signals that can induce stem cells to become differenti-
ated cell types such as muscle, insulin-producing islet cells,
skin or neurons. In a plenary session on recent progress in
defining the molecular components of stem cells, Janet
Rossant (University of Toronto, Canada) described tran-
scriptional profiling results from mouse embryonic stem
(ES) cells and trophoblast stem (TS) cells (the latter form the
extraembryonic placental tissue). Gene-expression signa-
tures from both ES and TS cells were identified, confirming
many of the known markers for these cells and identifying
novel genes, such as Esg-1, in ES cells. Esg-1 appears to be
associated with pluripotency, the ability to differentiate into
any of the embryonic cell types derived from ES cells. In
total, several hundred genes were newly identified as
expressed in either ES or TS cell lines. Rossant also
described the development by her group of powerful trans-
genic technology for RNAi in ES-derived embryos, which
promises to allow the genes identified through the micro-
array experiments to be rapidly characterized.
In the same session, Nissim Benvenisty (Hebrew University,
Jerusalem, Israel) described how human ES cells can be
induced to produce embryoid bodies that contain differenti-
ated tissue. His group has used microarrays to show that
genes indicative of a large range of tissue types were induced
in these embryoid bodies, depending on which signaling
pathways were stimulated. This work could speed up the
identification of the right combinations of stimuli required
to produce desired tissue differentiation patterns for use in
transplantation medicine. As Rossant’s and Benvenisty’s
groups have used expression profiling in mice and human
ES cells, respectively, it will be interesting, and hopefully
informative, to compare these parallel datasets. 
Developmental biologists are capitalizing on the rapid
succession of whole-genome sequences that have become
available for their model systems. Technologies that depend
on knowing gene-sequence information, such as morpholino
knock-down and RNAi, are now widespread. Mining the
sequence data and the accumulating functional-genomic
data is giving new understanding of previous discoveries,
such as miRNAs, and driving the identification of novel mol-
ecules involved in a wide range of developmental processes.
Old questions in developmental biology take on new dimen-
sions, and new questions have appeared, as genomic
approaches provide new impetus to this venerable field.
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